CiberMed is proud to announce a partnership with industry leader Agilent. The new Agilent SureSelect CD CiberMed Tissue and Heme panels enable a workflow combining SureSelect with iSortTM for cellular profiling from bulk RNA-Seq data with enhanced sensitivity, accuracy, and robustness. The combined workflow overcomes key analytical challenges, including RNA degradation in FFPE specimens, to achieve best-in-class performance.